Infectious Diseases (except HIV/AIDS)

  1. Source terms for benchmarking models of SARS-CoV-2 transmission via aerosols and droplets

    1. Marc E. J. Stettler
    2. Robert T. Nishida
    3. Pedro M. de Oliveira
    4. Léo C. C. Mesquita
    5. Tyler J. Johnson
    6. Edwin R. Galea
    7. Angus Grandison
    8. John Ewer
    9. David Carruthers
    10. David Sykes
    11. Prashant Kumar
    12. Eldad Avital
    13. Asiri I. B. Obeysekara
    14. Denis Doorly
    15. Yannis Hardalupas
    16. David C. Green
    17. Simon Coldrick
    18. Simon Parker
    19. Adam M. Boies

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Demographic Characteristics and Clinical Features of COVID-19 Patients Admitted in a Combined Military Hospital of Bangladesh

    1. Sabiha Mahboob
    2. Fatema Johora
    3. Asma Akter Abbasy
    4. Fatiha Tasmin Jeenia
    5. Mohammad Ali
    6. Noor E Naharin
    7. Jannatul Ferdoush

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Dynamics of humoral and T-cell immunity after three BNT162b2 vaccinations in adults older than 80 years

    1. Addi J Romero-Olmedo
    2. Axel Ronald Schulz
    3. Svenja Hochstätter
    4. Dennis Das Gupta
    5. Heike Hirseland
    6. Daniel Staudenraus
    7. Bärbel Camara
    8. Kirsten Volland
    9. Véronique Hefter
    10. Siddhesh Sapre
    11. Verena Krähling
    12. Helena Müller-Kräuter
    13. Ho-Ryun Chung
    14. Henrik E Mei
    15. Christian Keller
    16. Michael Lohoff

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Evaluation of “Test to Return” after COVID ‐19 Diagnosis in a Massachusetts Public School District

    1. Sandra B. Nelson
    2. Isaac Ravi Brenner
    3. Elizabeth Homan
    4. Sarah Bott Lee
    5. Christine Bongiorno
    6. Nira R. Pollock
    7. Andrea Ciaranello

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring Hospitalization

    1. Giulia Lamacchia
    2. Alessio Mazzoni
    3. Michele Spinicci
    4. Anna Vanni
    5. Lorenzo Salvati
    6. Benedetta Peruzzi
    7. Sara Bencini
    8. Manuela Capone
    9. Alberto Carnasciali
    10. Parham Farahvachi
    11. Arianna Rocca
    12. Seble Tekle Kiros
    13. Lucia Graziani
    14. Lorenzo Zammarchi
    15. Jessica Mencarini
    16. Maria Grazia Colao
    17. Roberto Caporale
    18. Francesco Liotta
    19. Lorenzo Cosmi
    20. Gian Maria Rossolini
    21. Alessandro Bartoloni
    22. Laura Maggi
    23. Francesco Annunziato

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals

    1. Simone I. Richardson
    2. Vimbai Sharon Madzorera
    3. Holly Spencer
    4. Nelia P. Manamela
    5. Mieke A. van der Mescht
    6. Bronwen E. Lambson
    7. Brent Oosthuysen
    8. Frances Ayres
    9. Zanele Makhado
    10. Thandeka Moyo-Gwete
    11. Nonkululeko Mzindle
    12. Thopisang Motlou
    13. Amy Strydom
    14. Adriano Mendes
    15. Houriiyah Tegally
    16. Zelda de Beer
    17. Talita Roma de Villiers
    18. Annie Bodenstein
    19. Gretha van den Berg
    20. Marietjie Venter
    21. Tulio de Oliviera
    22. Veronica Ueckermann
    23. Theresa M. Rossouw
    24. Michael T. Boswell
    25. Penny L. Moore

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Strength and durability of antibody responses to BNT162b2 and CoronaVac

    1. Benjamin J. Cowling
    2. Irene O.L. Wong
    3. Eunice Y.C. Shiu
    4. Amber Y.T. Lai
    5. Samuel M.S. Cheng
    6. Sara Chaothai
    7. Kelvin K.H. Kwan
    8. Mario Martín-Sánchez
    9. Leo L.M. Poon
    10. Dennis K.M. Ip
    11. Gabriel M. Leung
    12. Nancy H.L. Leung
    13. J.S. Malik Peiris

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Comprehensive humoral and cellular immune responses to SARS-CoV-2 variants in diverse Chinese populations: A benefit perspective of national vaccination

    1. Jiwei Li
    2. Jing Wu
    3. Qiuyue Long
    4. Yanan Wu
    5. Xiaoyi Hu
    6. Yukun He
    7. Mingzheng Jiang
    8. Jia Li
    9. Lili Zhao
    10. Shuoqi Yang
    11. Xiaoyong chen
    12. Minghui Wang
    13. Jianshi Zheng
    14. Fangfang Wu
    15. Ruiliang Wu
    16. Lihong Ren
    17. Liang Bu
    18. Houzhao Wang
    19. Ke Li
    20. Lijuan Fu
    21. Guojun Zhang
    22. Yali Zheng
    23. Zhancheng Gao

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Favipiravir, lopinavir-ritonavir or combination therapy (FLARE): a randomised, double blind, 2x2 factorial placebo-controlled trial of early antiviral therapy in COVID-19

    1. David M Lowe
    2. Li-An K Brown
    3. Kashfia Chowdhury
    4. Stephanie Davey
    5. Philip Yee
    6. Felicia Ikeji
    7. Amalia Ndoutoumou
    8. Divya Shah
    9. Alexander Lennon
    10. Abhulya Rai
    11. Akosua A Agyeman
    12. Anna Checkley
    13. Nicola Longley
    14. Hakim-Moulay Dehbi
    15. Nick Freemantle
    16. Judith Breuer
    17. Joseph F Standing
    18. FLARE Investigators

    Reviewed by Rapid Reviews Infectious Diseases, ScreenIT

    3 evaluationsAppears in 2 listsLatest version Latest activity

  10. Persistence, prevalence, and polymorphism of sequelae after COVID-19 in unvaccinated, young adults of the Swiss Armed Forces: a longitudinal, cohort study (LoCoMo)

    1. Jeremy Werner Deuel
    2. Elisa Lauria
    3. Thibault Lovey
    4. Sandrine Zweifel
    5. Mara Isabella Meier
    6. Roland Züst
    7. Nejla Gültekin
    8. Andreas Stettbacher
    9. Patricia Schlagenhauf

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 201 of 716 Next